Advanced searches left 3/3

Metastatic adenocarcinoma Prostate - Europe PMC

Summarized by Plex Scholar
Last Updated: 06 November 2021

* If you want to update the article please login/register

Case Report: Systemic Treatment and Serial Genomic Sequencing of Metastatic Prostate Adenocarcinoma Progressing to Small Cell Carcinoma.

Little cell carcinoma/ neuroendocrine prostate cancer cells is a uncommon and very aggressive subtype of prostate cancer cells connected with an AR-null phenotype and visceral metastases. This study presents a 44-year-old man initially identified with metastatic hormone-sensitive prostatic adenocarcinoma. The person established liver metastases and seasoned stable disease for 4 months following etoposide incorporated with cisplatin and pembrolizumab. The prostate biopsy specimen also showed pure SCC. Furthermore, whole-exome sequencing was executed on both biopsy samplings of the thoracic vertebra at the beginning of castration resistance and that of critical vesicle after numerous lines of treatment failing. Growth biopsy and IHC evaluation must be duplicated at various stages of development, due to intrapatient spatial and temporal heterogeneity of adenocarcinoma versus SCC/NEPC.

Source link: https://europepmc.org/article/MED/34646773

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions